Skip to the page

Data / Form D filings / ColigoMed Inc.

ColigoMed Inc.: Form D filing

ColigoMed Inc., a technology company in Sunnyvale, CA, filed a Form D with the SEC in 2026. The latest, on February 10, 2026, reports $1.8 million sold of a $2 million offering to 35 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
440 N WOLFE RD., Sunnyvale, CA, 94085
Phone
(408) 835-7454
Industry
Other Technology
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2021
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
2079732

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Feb 10, 2026New notice$2,000,000$1,840,000$160,00035Dec 5, 2023sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Sabhapathi Naidu AnnamaneniExecutive Officer, Director, Promoter"Promoter" relationship is marked as this individual is a founder of the Issuer.

Other technology companies in California that filed recently

Every Form D from the week of Feb 9, 2026 · All recent filings in California · All recent Other Technology filings

Read from SEC EDGAR. Amount sold is what ColigoMed Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.